Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.
Nat Rev Clin Oncol. 2022 Jan;19(1):37-50. doi: 10.1038/s41571-021-00552-7. Epub 2021 Sep 27.
Nat Rev Clin Oncol. 2022.
PMID: 34580473
Review.